New secondary analysis from Eli Lilly and Company's (NYSE: LLY) Phase 3 clinical development program showed patients receiving lebrikizumab who were assessed at 16 weeks experienced improved or...

Breeder-centric hub of new cannabis clone genetics, carefully propagated in small batches and available only to select, hand-picked California growers. SACRAMENTO, Calif., May 1, 2023 /PRNewswire/...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in...

The Clinician, a global healthcare company redefining how care is measured and delivered, announced that they will be participating in the 2023 Digital Health Festival in Melbourne on the 6-7...

Nick Boyd, a renowned HR and retail management authority, recently gave a stirring keynote speech at HR Retail 2023 about the future of work in the retail industry. Recognized as one of the top 50...